- RAMOT at Tel Aviv University Ltd.
- From Israel
- Responsive
- Innovative Products and Technologies
Summary of the technology
This model is used to study the development of diseases such as obesity, atherosclerosis, and cancer, as well as aging and brain alterations. The model enables examination of potential therapeutic interventions to prevent these diseases. Studies use the model to monitor phenotypical changes related to the mother’s diet at different stages of development, i.e., embryo to adult offspring.
Project ID : 12-2011-205
Details of the Technology Offer
This model has been developed in mice and can be applied also to humans.
Humans: Specific fatty acids are fed to the mothers during pregnancy and their impact on the lipid profile ,gene expression and metabolism of the offspring can be assessed at birth and different stages of growth under normal or different environmental conditions. The model allows studying the development of different diseases, such as obesity, atherosclerosis, cancer, as well as aging and brain alterations.
The model allows also studying the intervention of therapeutic means to prevent disease. Studies can be conducted at different stages of disease development and the model can be used to monitor body changes due to mother’s diet from embryo stages to adult offspring.
Mice:Female mice are fed with diets rich in specific f.a. (saturated or unsaturated) during pregnancy and/or lactation. The offspring is raised on a regular diet or on a fat rich diet, and develops obesity, fatty liver, and insulin resistance, depending on the diet received in utero. The model allows studying the development of different diseases, such as obesity, atherosclerosis, cancer, as well as aging and brain alterations.
The model allows also studying the intervention of therapeutic means to prevent disease. Studies can be conducted at different stages of disease development and the model can be used to monitor body changes due to mother’s diet from embryo stages to adult offspring.
Contact:
Prof. Alicia Leikin-Frenkel,PhD
Room 201,Bert Strassburger Lipid Center,Sheba-Tel Hashomer
Tel Aviv, ISRAEL
Phone : 972-3-5302939;
Fax : 972-3-5304431
Mobile : 972-545301475
E-mail: alicia.leikin@sheba.health.gov.il